Literature DB >> 26921501

siRNA release from pri-miRNA scaffolds is controlled by the sequence and structure of RNA.

Paulina Galka-Marciniak1, Marta Olejniczak1, Julia Starega-Roslan1, Michal W Szczesniak2, Izabela Makalowska2, Wlodzimierz J Krzyzosiak3.   

Abstract

shmiRs are pri-miRNA-based RNA interference triggers from which exogenous siRNAs are expressed in cells to silence target genes. These reagents are very promising tools in RNAi in vivo applications due to their good activity profile and lower toxicity than observed for other vector-based reagents such as shRNAs. In this study, using high-resolution northern blotting and small RNA sequencing, we investigated the precision with which RNases Drosha and Dicer process shmiRs. The fidelity of siRNA release from the commonly used pri-miRNA shuttles was found to depend on both the siRNA insert and the pri-miR scaffold. Then, we searched for specific factors that may affect the precision of siRNA release and found that both the structural features of shmiR hairpins and the nucleotide sequence at Drosha and Dicer processing sites contribute to cleavage site selection and cleavage precision. An analysis of multiple shRNA intermediates generated from several reagents revealed the complexity of shmiR processing by Drosha and demonstrated that Dicer selects substrates for further processing. Aside from providing new basic knowledge regarding the specificity of nucleases involved in miRNA biogenesis, our results facilitate the rational design of more efficient genetic reagents for RNAi technology.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Artificial miRNA; Dicer; Drosha; RNAi; miRNA biogenesis; pri-miRNA-based shRNA

Mesh:

Substances:

Year:  2016        PMID: 26921501     DOI: 10.1016/j.bbagrm.2016.02.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  A CAG repeat-targeting artificial miRNA lowers the mutant huntingtin level in the YAC128 model of Huntington's disease.

Authors:  Anna Kotowska-Zimmer; Lukasz Przybyl; Marianna Pewinska; Joanna Suszynska-Zajczyk; Dorota Wronka; Maciej Figiel; Marta Olejniczak
Journal:  Mol Ther Nucleic Acids       Date:  2022-05-05       Impact factor: 10.183

2.  Safe and Efficient Silencing with a Pol II, but Not a Pol lII, Promoter Expressing an Artificial miRNA Targeting Human Huntingtin.

Authors:  Edith L Pfister; Kathryn O Chase; Huaming Sun; Lori A Kennington; Faith Conroy; Emily Johnson; Rachael Miller; Florie Borel; Neil Aronin; Christian Mueller
Journal:  Mol Ther Nucleic Acids       Date:  2017-04-14

3.  Evaluation Expression of Microrna-93 and Integrin Β8 in Different Types of Glioma Tumors

Authors:  Reza Malekpour Afshar; Hamid Reza Mollaei; Mahdieh Shokrizadeh; Maryam Iranpour
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

4.  Somatic Mutations in miRNA Genes in Lung Cancer-Potential Functional Consequences of Non-Coding Sequence Variants.

Authors:  Paulina Galka-Marciniak; Martyna Olga Urbanek-Trzeciak; Paulina Maria Nawrocka; Agata Dutkiewicz; Maciej Giefing; Marzena Anna Lewandowska; Piotr Kozlowski
Journal:  Cancers (Basel)       Date:  2019-06-08       Impact factor: 6.639

5.  Universal RNAi Triggers for the Specific Inhibition of Mutant Huntingtin, Atrophin-1, Ataxin-3, and Ataxin-7 Expression.

Authors:  Anna Kotowska-Zimmer; Yuliya Ostrovska; Marta Olejniczak
Journal:  Mol Ther Nucleic Acids       Date:  2019-12-18       Impact factor: 8.886

6.  MiRNA-Embedded ShRNAs for Radiation-Inducible LGMN Knockdown and the Antitumor Effects on Breast Cancer.

Authors:  Zhi-Qiang Zhang; Zhi Cao; Cong Liu; Rong Li; Wei-Dong Wang; Xing-Yong Wang
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.